Healthcare -
Biotechnology - NASDAQ - US
$ 2.475
-8.67 %
$ 176 M
Market Cap
-1.63
P/E
CCCC - LONG-TERM DEBT
Long-term Debt CCCC - C4 Therapeutics, Inc.
65.8 M
LAST VALUE
-4.65%
2 YEAR CAGR
36.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR